E B Arushanian. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AnimalsAntipsychotic Agents/adverse effectsCatsCholinergic Fibers/physiologyCorpus Striatum/physiopathologyDopamine/physiologyDyskinesia, Drug-Induced/drug therapyDyskinesia, Drug-Induced/etiologyEndorphins/physiologyHaloperidol/adverse effectsHumansMiceNeurotransmitter Agents/physiologyParkinson Disease, Secondary/chemically inducedParkinson Disease, Secondary/drug therapyParkinson Disease, Secondary/physiopathologyReceptors, Neurotransmitter/physiologySerotonin/physiologySubstantia Nigra/physiopathologySynaptic Transmissiongamma-Aminobutyric Acid/physiology
Substances: See more » Antipsychotic AgentsEndorphinsNeurotransmitter AgentsReceptors, NeurotransmitterSerotoningamma-Aminobutyric AcidHaloperidolDopamine
Year: 1985 PMID: 2858951
Source DB: PubMed Journal: Zh Nevropatol Psikhiatr Im S S Korsakova ISSN: 0044-4588